Login to Your Account

Other News To Note

Wednesday, February 22, 2012
• BioLineRx Ltd., of Jerusalem, said it is raising about $15 million through agreements with U.S. institutional investors to place about 5.2 million American depositary shares (ADSs) priced at $2.86 each, along with warrants to purchase up to 2.6 million additional ADSs at an exercise price of $3.57. Net proceeds are expected to total about $14.1 million and will be used for working capital and for continued development of the firm's 18 compounds.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription